Learn more
In this section, you will learn more about Gattefossé Pharmaceuticals expertise, through news, hot topics and publications at the cutting edge of science, you can browse through a library of on-demands webinars, and download our latest brochures.
News and hot topics
Lifecycle Management and Reformulation Opportunities with Lipid Excipients
06 Apr 2026
Discover how lipid-based drug delivery systems solve complex 505(b)(2) reformulation challenges. Learn proven strategies to mitigate food effect, enable injectable-to-oral switches, and accelerate speed to market for patient-centric therapies.
Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms
Reading : 1mn
Learn how established lipid chemistries offer a safe, scalable approach to overcome in vivo barriers and accelerate your next tablet formulation to market.
Oral peptide delivery with lipid-based excipients
In this article, we explore why lipids and peptides are compatible, how lipid based formulations can address key peptide oral delivery challenges, and how Gattefossé supports formulators in this rapidly evolving field.
Webinars
Great science for the smallest things - Innovative solutions for streamlining nanopharmaceutical production
Gattefossé Pharmaceuticals gathers with Skyepharma and RCPE to decipher the innovative solutions for streamlining nanopharmaceutical production. Technical experts will share insights obtained during the NanoFacT consortium.
From Concept to Optimization: A Step-by-Step Guide to SEDDS for Enhanced Oral Bioavailability
Join Dr. Masumi Dave, Application Lab Manager at Gattefossé USA, for a practical, step-by-step guide to developing optimized Self-Emulsifying Drug Delivery Systems (SEDDS). This webinar provides a proven framework you can apply in your lab immediately.
Latest Publications
Advantages of combining cellulosic polymers and lipids in extruded 3D printing filaments. Part II 3D printing (FDM) and printlets characterization
Mar 2026
In this second poster of this collaboration between Gattefossé, ShinEtsu and ThermoFisher, various combinations of lipid excipients and TYLOPUR® 605 (Hypromellose 2910) were extruded, printed with an active pharmaceutical ingredient (API), and comprehensively characterized.
Formulation Strategies to Improve Drug Absorption: The Role of Lipid-Based Formulations and Permeation Enhancers
Mar 2026
This work compared ticagrelor permeability in Caco-2 monolayers versus Caco-2/HT29-MTX (70:30) co-cultures to assess the impact of mucus and how lipid excipients modulate intestinal permeability.
- Co-culture model
